Lactiga Announces NIH-Funded Partnership with Mount Sinai

Oct 14, 2020 | Awards & Announcements

Lactiga announced today a collaboration agreement with the Icahn School of Medicine at Mount Sinai to advance preclinical research into LCTG-001 as a potential treatment for COVID-19 patients. The collaborative partners secured an NIH R01 Emergency Award of over $2MM to advance this study.